510(k) Report

510(k) · Cleared

Recalled · Class III · 2012

Optigen Allergen Specific Ige Assay

K051677510(k) TraditionalCleared Jan 23, 2006216-day reviewClass II21 CFR 866.5750Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hitachi Chemical Diagnostics, Inc. · DHB System, Test, Radioallergosorbent (Rast) Immunological

Cleared on Jan 23, 2006 as substantially equivalent to K030590 (Hitachi Chemical Diagnostics, Inc., 2003) and 1 other predicate after a 216-day review. Its family tree reaches back 4 generations to 1995. It has been recalled once.

Decided
Jan 23, 2006
Review
216 days
Class
Class II
Product code
DHB
Recalls
1
Predicates
2

Its longest line of descent runs back 4 generations to K953014 (1995). 6 ancestors in all, the oldest K914850 (1991). No later device cites it as a predicate yet.

  1. Root · 4 generations backK953014 Alastat Microplate Latex-Specific Ige AllergenDiagnostic Products Corp. · 1995
  2. 3 generations backK962976 Pharmacia Cap System Rast FeiaPharmacia & Upjohn Co. · 1996
  3. 2 generations backK972068 Unicap Specific Ige Feia Assay, Latex Allergen Immunocap K82Pharmacia, Inc. · 1997
  4. 1 generation backK030590 Cla Allergen-Specific Ige Assay-Latex Allergen (K82)Hitachi Chemical Diagnostics, Inc. · 2003
  5. This deviceK051677 Optigen Allergen Specific Ige AssayHitachi Chemical Diagnostics, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K953014Alastat Microplate Latex-Specific Ige AllergenDiagnostic Products Corp.1995—
−3K962976Pharmacia Cap System Rast FeiaPharmacia & Upjohn Co.1996—
−2K972068Unicap Specific Ige Feia Assay, Latex Allergen Immunocap K82Pharmacia, Inc.1997—
−1K030590Cla Allergen-Specific Ige Assay-Latex Allergen (K82)Hitachi Chemical Diagnostics, Inc.2003—
0 (this device)K051677Optigen Allergen Specific Ige AssayHitachi Chemical Diagnostics, Inc.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199610
FIG. 1 — Lineage of K051677, 1995–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DHB device

  1. #1 K260331 IMMULITE 2000 3gAllergy Specific IgE Vantage…score 12.3 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K030590Cla Allergen-Specific Ige Assay-Latex Allergen (K82)
Summary page 2
…6. Substantial Equivalence to: Assay a. Hitachi Chemical Diagnostics, CLA Allergen-Specific IgE Assay - Latex Allergen K82 (K030590) b. Pharmacia, Inc., UniCAP Specific IgE Assay (K962274) 7. Device Description a. The OPTIGEN® Aller…
Hitachi Chemical Diagnostics, Inc.2003—
*K962274Unicap 100
Summary page 2
…a. Hitachi Chemical Diagnostics, CLA Allergen-Specific IgE Assay - Latex Allergen K82 (K030590) b. Pharmacia, Inc., UniCAP Specific IgE Assay (K962274) 7. Device Description a. The OPTIGEN® Allergen-Specific IgE Assay is a solid phase in vitro test…
Pharmacia, Inc.1996—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Dec 21, 2012Class IIIZ-0793-2013Process controlThere is no evidence that a visual inspection was performed on one tray of coverslips. Possibility of a low fill volume which could lead to a false negative results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 4 companies; a new generation was cleared every 2.8 years on median.
  • None of the 6 ancestors has a recall.

How does its category compare?

All DHB devices

DHB System, Test, Radioallergosorbent (Rast) Immunological: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DHB

2in 2025

2007: 12008: 22009: 72010: 32011: 52012: 32013: 52014: 12015: 12016: 22017: 12018: 22019: 32020: 22021: 12022: 22025: 22026 (partial year): 6
2007high 7 (2009) · low 0 (2023)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHB

90in 2019

2009: 118 days median2010: 247 days median2011: 405 days median2012: 260 days median2013: 257 days median2019: 90 days median2026 (partial year): 138 days median
2007high 405 (2011) · low 90 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DHB

14in 2025

2012: 12014: 12017: 12018: 12022: 32025: 14
2007high 14 (2025) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHB

6in 2025

2008: 12011: 12012: 22015: 12017: 112018: 62019: 42021: 72022: 12023: 62024: 102025: 6
2007high 11 (2017) · low 0 (2007)2025

MAUDE reports naming product code DHB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20082—01
2009711800
2010324700
2011540501
2012326012
2013525700
20141—10
20151—01
20162—00
20171—111
20182—16
201939004
20202—00
20211—07
20222—31
20230—06
20240—010
20252—146
202661380—

What is it indicated for?

The OPTIGEN assay is an in vitro test, which provides a semi quantitative

measurement of circulating allergen specific IgE antibodies in human serum. The

OPTIGEN assay is intended to assist in the clinical diagnosis of IgE-mediated allergic

disorders. This device is designed for use in clinical laboratories.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051677: Optigen Allergen Specific Ige Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051677

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026